- Home
- ALZN vs XWEL Comparison
ALZN vs XWEL Comparison
Compare ALZN & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- XWEL
- Stock Information
- Founded
- ALZN 2016
- XWEL 2006
- Country
- ALZN United States
- XWEL United States
- Employees
- ALZN N/A
- XWEL N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- XWEL Other Consumer Services
- Sector
- ALZN Health Care
- XWEL Consumer Discretionary
- Exchange
- ALZN Nasdaq
- XWEL Nasdaq
- Market Cap
- ALZN 6.1M
- XWEL 5.7M
- IPO Year
- ALZN 2021
- XWEL N/A
- Fundamental
- Price
- ALZN $1.00
- XWEL $1.01
- Analyst Decision
- ALZN Strong Buy
- XWEL
- Analyst Count
- ALZN 1
- XWEL 0
- Target Price
- ALZN $20.00
- XWEL N/A
- AVG Volume (30 Days)
- ALZN 210.7K
- XWEL 95.5K
- Earning Date
- ALZN 03-10-2025
- XWEL 05-14-2025
- Dividend Yield
- ALZN N/A
- XWEL N/A
- EPS Growth
- ALZN N/A
- XWEL N/A
- EPS
- ALZN N/A
- XWEL N/A
- Revenue
- ALZN N/A
- XWEL $33,833,000.00
- Revenue This Year
- ALZN $322.64
- XWEL $22.75
- Revenue Next Year
- ALZN N/A
- XWEL N/A
- P/E Ratio
- ALZN N/A
- XWEL N/A
- Revenue Growth
- ALZN N/A
- XWEL 11.79
- 52 Week Low
- ALZN $0.64
- XWEL $0.74
- 52 Week High
- ALZN $15.06
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- ALZN 51.86
- XWEL 45.49
- Support Level
- ALZN $0.95
- XWEL $0.95
- Resistance Level
- ALZN $1.13
- XWEL $1.33
- Average True Range (ATR)
- ALZN 0.09
- XWEL 0.21
- MACD
- ALZN 0.02
- XWEL 0.01
- Stochastic Oscillator
- ALZN 65.13
- XWEL 37.74
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.